Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Plant extracts may help treat hormone-related hair loss.

Pregnant female urologists should avoid certain drugs and use protective measures to stay safe.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Dermatologists should guide patients on blood donation timing due to various eligibility criteria.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Finasteride may cause infertility in rats by affecting epididymis and sperm function.

Finasteride doesn't change polycystic ovary size or cyst number, suggesting testosterone's role in their appearance.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Finasteride may worsen blood sugar control in diabetic patients.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.